GILLETTE MEDICAL EVALUATION LABORATORIES -- LIQUID PAPER CORRECTION FLUID (COLORS, LPCF-17) -- 7510-00N063192
=====================  Product Identification  =====================

Product ID:LIQUID PAPER CORRECTION FLUID (COLORS, LPCF-17)
MSDS Date:01/05/1995
FSC:7510
NIIN:00N063192
=== Responsible Party ===
Company Name:GILLETTE MEDICAL EVALUATION LABORATORIES
Address:401 PROFESSIONAL DR
City:GAITHERSBURG
State:MD
ZIP:20879
Country:US
Info Phone Num:301-590-9781
Emergency Phone Num:301-590-9781
CAGE:9A977
=== Contractor Identification ===
Company Name:GILLETTE MEDICAL EVALUATION LABORATORIES
Address:1413 RESEARCH BOULEVARD
City:ROCKVILLE
State:MD
ZIP:20850
Phone:301-424-2000
CAGE:9A977

=============  Composition/Information on Ingredients  =============

Ingred Name:CYCLOHEXANE, METHYL-; (METHYLCYCLOHEXANE)
CAS:108-87-2
RTECS #:GV6125000
OSHA PEL:500 PPM
ACGIH TLV:400 PPM

Ingred Name:TITANIUM OXIDE; (TITANIUM DIOXIDE)
CAS:13463-67-7
RTECS #:XR2275000
OSHA PEL:15 MG/M3 TDUST
ACGIH TLV:10 MG/M3 TDUST

Ingred Name:NAPHTHA, HEAVY ALKYLATE; (MINERAL SPIRITS)
CAS:64741-65-7
OSHA PEL:300 PPM
ACGIH TLV:300 PPM

Ingred Name:RESIN
OSHA PEL:N/K 
ACGIH TLV:N/K 

Ingred Name:DISPERSANT
OSHA PEL:N/K 
ACGIH TLV:N/K 

Ingred Name:COLORANT
OSHA PEL:N/K 
ACGIH TLV:N/K 

Ingred Name:ISOTHIOCYANIC ACID, ALLYL ESTER; (MUSTARD OIL)
CAS:57-06-7
RTECS #:NX8225000
OSHA PEL:N/K 
ACGIH TLV:N/K 

Ingred Name:FRAGRANCE; (MASKING FRAGRANCE)
OSHA PEL:N/K 
ACGIH TLV:N/K 

=====================  Hazards Identification  =====================

LD50 LC50 Mixture:LD50 (ORAL RAT): > 5 ML/KG.
Routes of Entry: Inhalation:YES  Skin:YES  Ingestion:YES
Reports of Carcinogenicity:NTP:NO    IARC:NO	OSHA:NO
Health Hazards Acute and Chronic:ACUTE: INHAL: NO ADVERSE EFTS
    ANTICIPATED FROM NORM USE. IF VAPS ARE DELIBERATELY CONC & INHALED
    (ABUSE), THE FOLLOWING SYMP MAY OCCUR: RESP IRRIT, DIZZ, DROW,
    HDCH, NAUS, UNCON, CONVULSIONS, CARD SEN SIT, COMA & DEATH.
    (MUSTARD OIL IS ADDED TO PROD AS ABUSE DETERRENT). INGEST: NO
    ADVERSE EFTS (EFTS OF OVEREXP)
Explanation of Carcinogenicity:NOT RELEVANT.
Effects of Overexposure:HLTH HAZ: ANTICIPATED FROM NORM USE. DEPENDING
    ON AMT INGESTED, MOST OF THE SYMP DESCRIBED ABOVE MAY OCCUR. ASPIR
    MAY RSLT IN CHEM PNEUMIT. SKIN CONT: NO ADVERSE EFTS ANTICIPATED
    FROM NORM USE. IRRIT  MAY OCCUR IF CONT IS PRLNG/RPTD. SKIN
    ABSORPTION: NO ADVERSE EFTS ANTICIPATED FROM NORM USE. SOLV CAN BE
    (SUP DAT)
Medical Cond Aggravated by Exposure:NONE SPECIFIED BY MANUFACTURER.

=======================  First Aid Measures  =======================

First Aid:EYES: FLUSH W/PLENTY OF WATER FOR AT LEAST 15 MIN. IF IRRIT
    PERSISTS, OBTAIN MED ATTN. SKIN: WASH W/SOAP & WATER. INHAL: IN AN
    ABUSE SITUATION, REMOVE FROM SOURCE OF EXPOS. TREAT
    SYMPTOMATICALLY. OXYG EN MAY BE ADMIN. SEEK MED ATTN IMMED & REFER
    TO "NOTES TO MD" BELOW. INGEST: CONSULT MD. NOTES TO MD: CONTAINS
    METHYLCYCLOHEXANE & MINERAL SPIRITS WHICH, IF ASPIR, MAY CAUSE CHEM
    PNEUMIT. (SUP DAT)

=====================  Fire Fighting Measures  =====================

Flash Point Method:CC
Flash Point:25.0F,-3.9C
Lower Limits:1.2%
Upper Limits:6.7%
Extinguishing Media:USE DRY CHEMICAL, FOAM, CARBON DIOXIDE.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED SCBA & FULL
    PROTECTIVE EQUIPMENT . COOL FIRE-EXPOSED CONTAINERS WITH WATER
    FOG/SPRAY.
Unusual Fire/Explosion Hazard:PRODUCT IS FLAMMABLE. MAY PRODUCE
    HAZARDOUS DECOMPOSITION PRODUCTS.

==================  Accidental Release Measures  ==================

Spill Release Procedures:PICK UP SPILLS WITH TOWELS, TISSUES, ETC.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

======================	Handling and Storage  ======================

Handling and Storage Precautions:PRODUCT IS FLAMMABLE. NO UNUSUAL
    HANDLING OR STORAGE WHEN USED AS DIRECTED.
Other Precautions:WHEN STORED IN LARGE QUANTITIES (AS IN WAREHOUSE), IT
    SHOULD BE IN WELL-VENTILATED, COOL AREA, AWAY FROM IGNITION
    SOURCES. PRODUCT IS NON-HAZARDOUS WHEN USED AS DIRECTED IN AN
    OFFICE/ROOM WITH NORMAL  AIR CIRCULATION.

=============  Exposure Controls/Personal Protection  =============

Respiratory Protection:NONE UNDER NORMAL USE CONDITIONS. USE NIOSH/MSHA
    APPROVED RESPIRATOR APPROPRIATE FOR EXPOSURE OF CONCERN .
Ventilation:NONE UNDER NORMAL USE CONDITIONS.
Protective Gloves:NONE UNDER NORMAL USE CONDITIONS.
Eye Protection:NONE UNDER NORMAL USE CONDITIONS.
Other Protective Equipment:EMERGENCY EYEWASH & DELUGE SHOWER MEETING
    ANSI DESIGN CRITERIA .
Work Hygienic Practices:NONE SPECIFIED BY MANUFACTURER.
Supplemental Safety and Health
EFTS OF OVEREXP: ABSORBED THRU SKIN (PRLNG CONT), BUT NOT LIKELY IN
    ACUTELY TOX AMTS. EYES: IRRIT CAN OCCUR. CHRONIC: NONE SPECIFIED BY
    MANUFACTURER. FIRST AID PROC: INHAL OF CONC VAPS MAY PRODUCE CAR D
    SENSIT, CONTRAINDICATING USE OF SYMPATHOMIMETIC AGENTS.

==================  Physical/Chemical Properties  ==================

Boiling Pt:B.P. Text:212F,100C
Vapor Pres:83 @ 100F
Vapor Density:3.4
Spec Gravity:1.3 (H*2O=1)
Evaporation Rate & Reference:>1 (BUTYL ACETATE=1)
Solubility in Water:NEGLIGIBLE
Appearance and Odor:COLORED FLUID, WITH A PUNGENT SOLVENT ODOR
Percent Volatiles by Volume:40

=================  Stability and Reactivity Data  =================

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZERS.
Stability Condition to Avoid:PRODUCT IS FLAMMABLE. AVOID CONTACT WITH
    OPEN FLAME OR OTHER IGNITION SOURCES.
Hazardous Decomposition Products:THERMAL DECOMPOSITION MAY PRODUCE
    OXIDES OF CARBON AND NITROGEN AND VARIOUS HYDROCARBONS.

====================  Disposal Considerations  ====================

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE W/LOCAL, STATE &
    FEDERAL REGULATIONS.

 Disclaimer (provided with this information by the compiling agencies):
 This information is formulated for use by elements of the Department
 of Defense.  The United States of America in no manner whatsoever,
 expressly or implied, warrants this information to be accurate and
 disclaims all liability for its use.  Any person utilizing this
 document should seek competent professional advice to verify and
 assume responsibility for the suitability of this information to their
 particular situation.